Using rare coding variants in SLC5A2 to explore the impact of SGLT2 inhibitors on cardiorenal outcomes.

Research paper from Europe PMC. Evidence status: source reported.

Published

2026-10-26

Source reference

MED:42932779

DOI

10.1093/eurjpc/zwag539

Jurisdiction

Not assessed

Licence

Bibliographic metadata only; article rights retained

Wang S, Nolte IM, Groothof D, Qin H, Bakker SJL, van der Harst P, Snieder H. · Eur J Prev Cardiol · im; journal article · Found via: UK Biobank

Source: https://europepmc.org/article/MED/42932779. Captured 2026-10-27.

Limitations: Discovered through a Europe PMC keyword search for UK Biobank. A mention is not a verified link to an access authorisation, project, dataset or clinical outcome. Preprints may not be peer reviewed.